Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2010

01-12-2010 | Retraction Note

Erratum to: NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development

Authors: D. Tamiolakis, N. Papadopoulos, J. Venizelos, M. Lambropoulou, P. Tsikouras, G. Koutsougeras, S. Bolioti, M. Tsiapali, M. Menegaki, C. Kouskoukis

Published in: Clinical and Experimental Medicine | Issue 4/2010

Login to get access

Excerpt

This article [1] was submitted and subsequently published in Clinical and Experimental Medicine shortly after submitting and publishing analogous articles in [2, 3] Romanian Journal of Biophysics and Acta Dermatovenereologica Alpina, Pannonica et Adriatica. Since the three articles published by the same research group resemble each other in that way that 90–95% of the text is identical, we consider this as triplicate publication. The Editor-in-Chief and the publisher consider this as a serious ethical misconduct and therefore the decision has been made to retract the article published in Clinical and Experimental Medicine.
Literature
1.
go back to reference Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Menegaki M, Kouskoukis C (2005) NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med 5(4):184–189CrossRefPubMed Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Menegaki M, Kouskoukis C (2005) NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med 5(4):184–189CrossRefPubMed
2.
go back to reference Tamiolakis D, Menegaki M, Nikolaidou S, Papadopoulos E, Bolioti S, Pavlidis P, Tzilivaki A, Papadopoulos N (2004) Occurrence of CD30 antigen on tissues and cells other than lymphoid origin. A study of human fetal skin in 8th, 10th, and 12th gestational weeks. Roman J Biophys 14:59–67 Tamiolakis D, Menegaki M, Nikolaidou S, Papadopoulos E, Bolioti S, Pavlidis P, Tzilivaki A, Papadopoulos N (2004) Occurrence of CD30 antigen on tissues and cells other than lymphoid origin. A study of human fetal skin in 8th, 10th, and 12th gestational weeks. Roman J Biophys 14:59–67
3.
go back to reference Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Karpouzis A, Kouskoukis C (2005) CD30 (Ki-1) molecule expression in human embryonal epithelial cells of the basal layer of the developing epidermis and epidermal buds and its potential significance for embryogenesis. Acta Dermatovenerol Alp Pannonica Adriat 14(3):85–90 Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Karpouzis A, Kouskoukis C (2005) CD30 (Ki-1) molecule expression in human embryonal epithelial cells of the basal layer of the developing epidermis and epidermal buds and its potential significance for embryogenesis. Acta Dermatovenerol Alp Pannonica Adriat 14(3):85–90
Metadata
Title
Erratum to: NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development
Authors
D. Tamiolakis
N. Papadopoulos
J. Venizelos
M. Lambropoulou
P. Tsikouras
G. Koutsougeras
S. Bolioti
M. Tsiapali
M. Menegaki
C. Kouskoukis
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2010
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-010-0111-8

Other articles of this Issue 4/2010

Clinical and Experimental Medicine 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.